NewHold Investment Corp IV (NHIV) is a special purpose acquisition company (SPAC) focused on identifying and merging with high-growth businesses primarily in the technology and healthcare sectors. Leveraging its capital and industry expertise, NHIV aims to foster the development of innovative companies poised for significant growth. The firm is committed to value creation through strategic partnerships while positioning itself to capitalize on emerging market trends. Led by a team of seasoned professionals with extensive experience in operational management and investment, NewHold Investment Corp IV is well-equipped to drive successful mergers and generate substantial returns for its investors.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.01 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $20.77M |
| Float | $19.29M |
| % Insiders | 0.00% |
| % Institutions | 5.66% |
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on NHIV and any ticker you trade — then tracks every position and per-strategy win rate.